Historial development of tuberculosis since Robert Koch's discovery of the tubercle bacillus in 1882;Die historische entwicklung der tuberkulose seit Robert Kochs entdeckung des tuberkelbazillus 1882

Pneumologie

Volumn 61, Issue 12, 2007, Pages 764-770

  Murray, John F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b International Union Against Tuberculosis and Lung Disease   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; X RAY;

GERMANY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; TUBERCULOSIS;

EID: 38349039282     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993029     Document Type: Review

References (28)

1. Koch R. Die Aetiologie der Tuberculose. Berlin Klin Wschr 1882; 19: 221-230
2. Global tuberculosis control: surveillance, planning, financing. WHO Report 2007. Geneva: World Health Organization. WHO/HTM/TB/2007.376, 2007
3. CDC, Deaths: preliminary data for 2004. Nat Vital Stat Rep 2006; 54: 1-50
4. Röntgen WC. Ueber eine neue Art von Strahlen. Würzburg: Physikalisch-Medizinische Gesellschaft, 28. Dezember 1895
5. Lentle B, Aldrich J. Radiological sciences, past and present. Lancet 1997; 350: 280-285
6. Guérin C. The history of BCG. Chapter 3. In: Rosenthal SR (Hrsg). BCG Vaccine: Tuberculosis-Cancer. Littleton, MA, PSG Publishing Co, 1980: 35-43
7. Calmette A, Guérin C, Weill-Hatté B et al. Essais de prémunition par le BCG contre l'infection tuberculeuse de l'homme et des animaux. Bull Acad Med 1924; 91: 787
8. Dubos R, Dubos J. The white plague: tuberculosis, man and society. Boston, MA: Little Brown and Co, 1952: 123
9. Berlin Correspondent. The Lübeck trial. Lancet 1932; 1: 365
10. Fine PEM. BCG vaccines and vaccination. Chapter 19. In: Reichman LB, Hershfield ES (Hrsg). Tuberculosis. A Comprehensive International Approach. 2nd Ed. New York, NY: Marcel Dekker, 2000: 503-522
11. Han RE, Pan JG. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology 2006; 67: 1216-1223
12. Murray JF. A century of tuberculosis. Am J Respir Crit Care Med 2004; 169: 1181-1186
13. Ryan F. The forgotten plague: how the battle against tuberculosis was won and lost. Boston, MA: Little Brown, 1992: 251-261
14. Medical Research Council. Treatment of pulmonary tuberculosis with para-aminosalicylic acid and streptomycin: a preliminary report. BMJ 1949; 2: 1521
15. Ryan F. The forgotten plague: how the battle against tuberculosis was won and lost. Boston, MA: Little Brown, 1992: 359
16. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units 1946- 1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3 (Suppl 2): 231-279
17. WHO. The five elements of DOTS. http://www.who.int/tb/dots/ whatisdots/en/index.html am 6 April 2007,
18. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB2006.361. Geneva: World Health Organization, 2006
19. Migliori GB, Loddenkemper R. Blasi F et al. 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J 2007; 29: 423-427
20. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Bibl Tuberc 1970; 26: 28-106
21. Ferebee SH, Mount FW, Comstock CW. Controlled trials of isoniazid prophylaxis in the USA. T 1962; 3: 8-22
22. Ewer K, Deeks J, Alvarez I. et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173
23. Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infection. N Engl J Med 2002; 347: 1860-1866
24. Cole ST, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537-544
25. Huard RC, Babre M, de Haas P et al. Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex. J Bacteriol 2006; 188: 4271-4287
26. Murray JF. Mycobacterium tuberculosis and the cause of consumption: from discovery to fact. Am J Respir Crit Care Med 2004; 169: 1086-1088
27. De Jonge MI, Brosch R, Brodin P et al. Tuberculosis: from genome to vaccine. Expert Rev Vaccines 2005; 4: 541-551
28. Arcus VL, Lott JS, Johnston JM et al. The potential impact of structural genomics on tuberculosis drug discovery. Drug Discov Today 2006; 11: 28-34